Verdiva Bio Overview
- Year Founded
-
2024
- Status
-
Private
- Employees
-
43
- Latest Deal Type
-
Series A
- Latest Deal Amount
-
$411M
- Investors
-
7
Verdiva Bio General Information
Description
Developer of next-generation therapies designed to help people living with obesity, cardiometabolic disorders, and related complications. The company accelerates the development of differentiated medicines that address unmet medical needs in gut-brain biology and include multiple amylin molecules, enabling users to access the potential for enhanced efficacy, improved tolerability, and healthier weight loss.
Contact Information
Website
www.verdivabio.comCorporate Office
- 25 Austen Road
- Guildford GU1 3NP
- England, United Kingdom
Corporate Office
- 25 Austen Road
- Guildford GU1 3NP
- England, United Kingdom
Verdiva Bio Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 1. Early Stage VC (Series A) | 09-Jan-2025 | $411M | Completed | Clinical Trials - Phase 2 |
Verdiva Bio Signals
Verdiva Bio Investors (7)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Forbion | Venture Capital | Minority | ||
| General Atlantic | Growth/Expansion | Minority | ||
| LAV (Lilly Asia Fund) | Corporate Venture Capital | Minority | ||
| Logos Capital | Hedge Fund | Minority | ||
| LYFE Capital | PE/Buyout | Minority |
Verdiva Bio FAQs
-
When was Verdiva Bio founded?
Verdiva Bio was founded in 2024.
-
Where is Verdiva Bio headquartered?
Verdiva Bio is headquartered in Guildford, United Kingdom.
-
What is the size of Verdiva Bio?
Verdiva Bio has 43 total employees.
-
What industry is Verdiva Bio in?
Verdiva Bio’s primary industry is Drug Discovery.
-
Is Verdiva Bio a private or public company?
Verdiva Bio is a Private company.
-
What is Verdiva Bio’s current revenue?
The current revenue for Verdiva Bio is .
-
How much funding has Verdiva Bio raised over time?
Verdiva Bio has raised $411M.
-
Who are Verdiva Bio’s investors?
Forbion, General Atlantic, LAV (Lilly Asia Fund), Logos Capital, and LYFE Capital are 5 of 7 investors who have invested in Verdiva Bio.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process